Time to retreat from all stocks with strong dependencies to market in China. The regulatory risk is just too high. IMO DYOR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025